2004 drug approval highlights: FDA update

Nurse Pract. 2005 Feb;30(2):14-29; quiz 29-31. doi: 10.1097/00006205-200502000-00004.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Amlodipine / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Antidepressive Agents / pharmacology
  • Bronchodilator Agents / pharmacology
  • Cardiovascular Agents / pharmacology*
  • Drug Approval*
  • Drug Combinations
  • Duloxetine Hydrochloride
  • Eplerenone
  • Estradiol / administration & dosage*
  • Excitatory Amino Acid Antagonists
  • Female
  • Gastrointestinal Agents / pharmacology
  • Heptanoic Acids / pharmacology
  • Humans
  • Ketolides / pharmacology
  • Male
  • Memantine / pharmacology*
  • Osteoporosis, Postmenopausal / drug therapy
  • Pyrroles / pharmacology
  • Rifamycins / pharmacology
  • Rifaximin
  • Scopolamine Derivatives / pharmacology*
  • Spironolactone / analogs & derivatives*
  • Spironolactone / pharmacology
  • Thiophenes / pharmacology*
  • Tiotropium Bromide
  • United States

Substances

  • Anti-Bacterial Agents
  • Antidepressive Agents
  • Bronchodilator Agents
  • Cardiovascular Agents
  • Drug Combinations
  • Excitatory Amino Acid Antagonists
  • Gastrointestinal Agents
  • Heptanoic Acids
  • Ketolides
  • Pyrroles
  • Rifamycins
  • Scopolamine Derivatives
  • Thiophenes
  • amlodipine, atorvastatin drug combination
  • Amlodipine
  • Spironolactone
  • Estradiol
  • Eplerenone
  • Duloxetine Hydrochloride
  • telithromycin
  • Rifaximin
  • Memantine
  • Tiotropium Bromide